ARS Pharmaceuticals, Inc. Operating Margin in % from 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
ARS Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from 2021 to Q3 2025.
  • ARS Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2025 was -63.6 %, a 97.3% increase year-over-year.
  • ARS Pharmaceuticals, Inc. annual Operating Margin for 2024 was -3.46 %, a 100% increase from 2023.
  • ARS Pharmaceuticals, Inc. annual Operating Margin for 2023 was -225K %, a 8240% decline from 2022.
  • ARS Pharmaceuticals, Inc. annual Operating Margin for 2022 was -2.7K %, a 664% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

ARS Pharmaceuticals, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -63.6 +2.29K +97.3% Jul 1, 2025 Sep 30, 2025
Q2 2025 -52.8 +11.3K +99.5% Apr 1, 2025 Jun 30, 2025
Q1 2025 -27.9 +620K +100% Jan 1, 2025 Mar 31, 2025
Q4 2024 -3.46 +225K +100% Oct 1, 2024 Dec 31, 2024
Q3 2024 -2.36K +240K +99% Jul 1, 2024 Sep 30, 2024
Q2 2024 -11.3K +16.7K +59.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -620K -613K -8753% Jan 1, 2024 Mar 31, 2024
Q4 2023 -225K -222K -8240% Oct 1, 2023 Dec 31, 2023
Q3 2023 -242K Jul 1, 2023 Sep 30, 2023
Q2 2023 -28K Apr 1, 2023 Jun 30, 2023
Q1 2023 -7K Jan 1, 2023 Mar 31, 2023
Q4 2022 -2.7K Oct 1, 2022 Dec 31, 2022

ARS Pharmaceuticals, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -3.46 +225K +100% Jan 1, 2024 Dec 31, 2024
2023 -225K -222K -8240% Jan 1, 2023 Dec 31, 2023
2022 -2.7K -2.35K -664% Jan 1, 2022 Dec 31, 2022
2021 -353 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.